Abstract
Patients suffering from Covid-19 often have leukopenia, most often lymphopenia, as an accompanying laboratory manifestation of the clinical syndrome, but there are indications that at the beginning of the disease they also have mild neutropenia. Clozapine can have hematological side effects in terms of leukopenia - most often neutropenia. The paper presents a patient with schizophrenia who is on long-term Clozapine therapy. At the time when leukopenia was detected in the blood count, he was mentally stable and physically asymptomatic. He had a reduced number of leukocytes as the only symptom of infection with the new coronavirus SARS CoV 2, which we confirmed by PCR. In this paper, we present the clinical picture of COVID-19 in connection with the possible overlapping etiology of leukopenia, which can also appear as a separate symptom of infection with the SARS CoV 2 coronavirus and be a hematological side effect of Clozapine treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
